Anixa Biosciences, Inc. (ANIX)
3.625
-0.08
(-2.29%)
USD |
NASDAQ |
Aug 24, 16:00
3.62
0.00 (0.00%)
After-Hours: 20:00
Anixa Biosciences Debt to Equity Ratio : 0.0127 for April 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| April 30, 2026 | 0.0127 |
| January 31, 2026 | 0.0128 |
| October 31, 2025 | 0.0135 |
| July 31, 2025 | 0.0128 |
| April 30, 2025 | 0.0138 |
| January 31, 2025 | 0.0129 |
| October 31, 2024 | 0.0116 |
| July 31, 2024 | 0.0109 |
| April 30, 2024 | 0.0063 |
| January 31, 2024 | 0.0066 |
| October 31, 2023 | 0.0072 |
| July 31, 2023 | 0.0073 |
| April 30, 2023 | 0.0074 |
| January 31, 2023 | 0.0075 |
| October 31, 2022 | 0.0076 |
| July 31, 2022 | 0.0073 |
| April 30, 2022 | 0.0075 |
| January 31, 2022 | 0.0074 |
| October 31, 2021 | 0.0073 |
| July 31, 2021 | 0.0003 |
| April 30, 2021 | 0.0007 |
| January 31, 2021 | 0.003 |
| October 31, 2020 | 0.0063 |
| July 31, 2020 | 0.008 |
| April 30, 2020 | 0.0155 |
| Date | Value |
|---|---|
| January 31, 2020 | 0.0173 |
| October 31, 2019 | 0.00 |
| July 31, 2019 | 0.00 |
| April 30, 2019 | 0.00 |
| January 31, 2019 | 0.00 |
| October 31, 2018 | 0.00 |
| July 31, 2018 | 0.00 |
| April 30, 2018 | 0.00 |
| January 31, 2018 | 0.00 |
| October 31, 2017 | 0.00 |
| July 31, 2017 | 0.3644 |
| April 30, 2017 | 0.8358 |
| January 31, 2017 | -1.915 |
| October 31, 2016 | 4.225 |
| July 31, 2016 | 2.146 |
| April 30, 2016 | 1.441 |
| January 31, 2016 | 1.062 |
| October 31, 2015 | 0.00 |
| July 31, 2015 | 0.00 |
| April 30, 2015 | 0.00 |
| January 31, 2015 | 0.00 |
| October 31, 2014 | 0.00 |
| July 31, 2014 | 0.341 |
| April 30, 2014 | 28.35 |
| January 31, 2014 | -3.257 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.956 |
| Oncolytics Biotech, Inc. | -0.0726 |
| Sangamo Therapeutics, Inc. | -1.020 |
| Sarepta Therapeutics, Inc. | 0.6845 |
| Vicapsys Life Sciences, Inc. | -0.1759 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 14.86M |
| Total Liabilities (Quarterly) | 1.641M |
| Shareholders Equity (Quarterly) | 14.48M |
| Current Ratio | 9.788 |
| Net Debt Paydown Yield | 0.01% |